About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Houston | 156 Studies

Clinical Trials Alzheimer's DiseaseHouston

Alzheimer's Disease Clinical Trials in Houston

Find 156 clinical trials for alzheimer's disease near Houston, Texas. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 156 trials

CompletedAlzheimer's Disease Neuroimaging Initiative 3Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD.NCT02854033·Birmingham, Alabama and 58 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedIdalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With DonepezilTo establish efficacy of Idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD).NCT02006641·Phoenix, Arizona and 161 others

CompletedAn Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of GalantamineThe purpose of the study is to collect data of patients who were randomized (assignment of study medication by chance) and treated in 3 previous studies of galantamine (CR003145…NCT00297414·Tucson, Arizona and 143 others

RecruitingStem Cell Therapy for Early Alzheimer's DiseaseThe goal of this clinical trial is to learn if stem cell therapy works to treat brain inflammation in adults.NCT06775964·Houston, Texas

CompletedA Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)The reason for this study is to collect safety and efficacy information regarding the study drug remternetug in participants with early symptomatic Alzheimer's disease (AD).NCT05463731·Chandler, Arizona and 75 others

WithdrawnA Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's DiseaseHope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible…NCT04228666·Houston, Texas

CompletedTo Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.The purpose of this study is to find out if atovastatin, when taken with a cholinesterase inhibitor, is effective for treating Alzheimer's disease.NCT00151502·Sun City, Arizona and 98 others

CompletedRegistry of Amyloid Positive Patients for Alzheimer's Disease Drug Research TrialsThis registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in…NCT02918539·Glendale, Arizona and 74 others

RecruitingEpidemiology and Biomarker Study in Alzheimer's DiseaseStudy AACU determines rates of cognitive worsening in participants within elevated and not elevated plasma P-tau217 cohorts. Participation in AACU will last approximately 7 years.NCT07142954·Houston, Texas and 3 others

Active not recruitingLongitudinal Early-onset Alzheimer's Disease Study ProtocolThe Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is a non-randomized, natural history, non-treatment study designed to look at disease progression in individuals…NCT03507257·Sun City, Arizona and 22 others

CompletedA Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With CrenezumabThis Phase II, open-label extension (OLE), multicenter study will evaluate the long-term safety and tolerability of crenezumab in participants with mild to moderate Alzheimer's…NCT01723826·Phoenix, Arizona and 85 others

CompletedRosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's DiseaseRosiglitazone (RSG) has been tested in clinical studies and is approved by the FDA as a treatment for type II diabetes mellitus, a disease that occurs when the body is unable to…NCT00348309·Litchfield Park, Arizona and 248 others

TerminatedA Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's DiseaseThe main purpose of this study is to investigate the safety and efficacy of the study drug solanezumab in participants with prodromal Alzheimer's disease (AD).NCT02760602·Phoenix, Arizona and 192 others

CompletedMemory Improvement Through Nicotine Dosing (MIND) StudyThe purpose of the study is to see if daily transdermal nicotine is able to produce a significant cognitive, clinical and functional improvement in participants with MCI.NCT02720445·Scottsdale, Arizona and 35 others

UnknownEvidence Amyloid Scan EEG StudyThe Evidence Amyloid Study EEG (EASE) establishes an open-label, longitudinal cohort study to measure of neurological functioning during the onset and progression of cognitive…NCT03644043·Houston, Texas

TerminatedEfficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's DiseaseThe aim of this study is to assess the efficacy and safety of GSK4527226 in participants with early Alzheimer's Disease (AD) (including mild cognitive impairment \[MCI\] and mild…NCT06079190·San Diego, California and 96 others

Not yet recruitingNovel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's DiseaseThe goal of this pilot study is to test a combination of two non-invasive brain stimulation methods, called iTBS (intermittent theta burst stimulation) and tDCS (transcranial…NCT06835283·Houston, Texas

CompletedEfficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's DiseaseThe objectives of the study are to evaluate the safety, tolerability and efficacy of AVP-923 compared to placebo, for the treatment of symptoms of agitation in participants with…NCT01584440·Phoenix, Arizona and 43 others

CompletedA Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the efficacy and safety of PF 04494700 in participants with mild to moderate Alzheimer's disease.NCT00566397·Phoenix, Arizona and 61 others

RecruitingA Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).The main purpose of this study is to determine if participants who previously took donanemab get clinical benefit when they receive annual doses.NCT07602582·Phoenix, Arizona and 61 others

Page 1 of 8Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia